Moderna: COVID Vaccine Sales Predicted to Reach $8B in 2023

Image copyright: Unsplash

The Spin

Narrative A

COVID is still a very real threat, with the market moves showing that Moderna is preparing for a COVID onslaught this fall, and we should heed the wisdom of the market. Moderna and Pfizer are preparing for such with targeted boosters that will help minimize the impact this time around.

Narrative B

Moderna has left governments around the world holding the bag, as the company has hidden data that showed that boosters weren't anymore effective than the original shots. Governments have spent billions on misleadingly advertised boosters, with the company now touting their new shot in a bid to boost flagging revenues.


Articles on this story

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!